![](https://news.europawire.eu/wp-content/uploads/2019/04/AstraZeneca-will-use-BenevolentAI-advanced-AI-to-dive-into-its-disease-area-expertise-and-massive-datasets-to-gain-insights-into-the-complex-disease-biology-144x144.png)
AstraZeneca / BenevolentAI artificial intelligence collaboration will accelerate drug discovery Potential new drugs discovery in the area of chronic kidney disease and idiopathic pulmonary fibrosis (PRESS RELEASE) CAMBRIDGE / LONDON, 30-Apr-2019 — /EuropaWire/ — New partnership, announced today, by AstraZeneca … Read the full press release